Evidence map›Paper›PMID 28157203›Full record

ArticleScientific reports2017

Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells.

Izabela Nita, Katrin Hostettler, Luca Tamo, Michaela Medová, Giuseppe Bombaci, Jun Zhong, Ramanjaneyulu Allam, Yitzhak Zimmer, Michael Roth, Thomas Geiser and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Role ofFrontiers in cell and developmental biology · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2018
    Article
  14. Article
  15. TRAIL-Dependent Resolution of Pulmonary Fibrosis.Mediators of inflammation · 2018
    Article
  16. Cell-Based Therapies for Tissue Fibrosis.Frontiers in pharmacology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Izabela NitaDepartment of Pulmonary Medicine, University Hospital Bern, Switzerland.
Katrin HostettlerPulmonary Cell Research, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
Luca TamoDepartment of Pulmonary Medicine, University Hospital Bern, Switzerland.
Michaela MedováDepartment of Clinical Research University of Bern, Switzerland.
Giuseppe BombaciDepartment of Clinical Research University of Bern, Switzerland.
Jun ZhongPulmonary Cell Research, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
Ramanjaneyulu AllamDepartment of Clinical Research University of Bern, Switzerland.
Yitzhak ZimmerDepartment of Clinical Research University of Bern, Switzerland.
Michael RothPulmonary Cell Research, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
Thomas GeiserDepartment of Pulmonary Medicine, University Hospital Bern, Switzerland.
Amiq GazdharDepartment of Pulmonary Medicine, University Hospital Bern, Switzerland.
University Hospital of Bern · CHUniversity Hospital of Basel · CHUniversity of Bern · CHBern University of Applied Sciences · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic Pulmonary Fibrosis (IPF) is a progressive, irreversible lung disease with complex pathophysiology. Evidence of endoplasmic reticulum (ER) stress has been reported in alveolar epithelial cells (AEC) in IPF patients. Secreted mediators from bone marrow stem cells (BMSC-cm) have regenerative properties. In this study we investigate the beneficial effects of BMSC-cm on ER stress response in primary AEC and ER stressed A549 cells. We hypothesize that BMSC-cm reduces ER stress. Primary AEC isolated from IPF patients were treated with BMSC-cm. To induce ER stress A549 cells were incubated with Tunicamycin or Thapsigargin and treated with BMSC-cm, or control media. Primary IPF-AEC had high Grp78 and CHOP gene expression, which was lowered after BMSC-cm treatment. Similar results were observed in ER stressed A549 cells. Alveolar epithelial repair increased in presence of BMSC-cm in ER stressed A549 cells. Hepatocyte growth factor (HGF) was detected in biologically relevant levels in BMSC-cm. Neutralization of HGF in BMSC-cm attenuated the beneficial effects of BMSC-cm including synthesis of surfactant protein C (SP-C) in primary AEC, indicating a crucial role of HGF in ER homeostasis and alveolar epithelial repair. Our data suggest that BMSC-cm may be a potential therapeutic option for treating pulmonary fibrosis.

Indexed as

Endoplasmic Reticulum StressAlveolar Epithelial CellsBone Marrow CellsCell Line, TumorCells, CulturedCulture Media, ConditionedEndoplasmic Reticulum Chaperone BiPHepatocyte Growth FactorHumansThapsigarginTunicamycinCulture Media, ConditionedEndoplasmic Reticulum Chaperone BiPHepatocyte Growth FactorHSPA5 protein, humanThapsigarginTunicamycin

Identifiers

PMID28157203
PMCPMC5291222
OpenAlexW2584459863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.